<?xml version="1.0" encoding="UTF-8"?>
<p>Increasingly, it is recognized that other organ systems, besides the pulmonary system, can be adversely affected by infection with SARS-CoV‑2. A retrospective, observational analysis of 214 confirmed cases of COVID-19, specifically studied those with severe pneumonia, using criteria established by the American Thoracic Society [
 <xref ref-type="bibr" rid="CR17">17</xref>]. Of those patients with severe pneumonia, 36.4% had neurological manifestations of disease, such as acute cerebrovascular disease (5.7%), impaired consciousness (14.8%) and skeletal muscle injury (19.3%). Coagulation disorders and cardiac manifestations of COVID-19 infection have also been reported [
 <xref ref-type="bibr" rid="CR18">18</xref>, 
 <xref ref-type="bibr" rid="CR19">19</xref>].
</p>
